Gedeon Richter - PregLem S.A.
Clive Scragg's work experience includes being a Retired individual at Evolve Selection in 2018. Prior to that, they worked at Gedeon Richter - PregLem S.A. as a Business Unit Director and National Sales Project Manager starting in 2013. From 2001 to 2012, Scragg was a Regional Business Director at sanofi-aventis, where they managed cross-functional sales and market access teams and played a key role in formulating operational and strategic marketing plans. Clive also held the position of Area Business Manager - Cardiovascular / Urology at sanofi-aventis. Before that, they worked at GlaxoSmithKline as a National Accounts Director and National Sales Manager Opportunity Growth Products.
Clive Scragg attended the University of East London from 1982 to 1985, where they obtained a Bachelor of Laws (LL.B.) degree with a focus on law.
This person is not in any teams
This person is not in any offices
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.